Economic Evaluation of Vaccination Programmes

Infectious Diseases of Humans: Dynamics and Control

1992 • 7,897 citations

Recommendations of the Panel on Cost-Effectiveness in Health and Medicine

1996 • 2,447 citations

Accounting for future costs in medical cost-effectiveness analysis

1997 • 447 citations

Are booster immunisations needed for lifelong hepatitis B immunity?

2000 • 431 citations

Discounting and health benefits

1992 • 229 citations

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

1999 • 206 citations

Discounting for health effects in cost–benefit and cost‐effectiveness analysis

2001 • 169 citations

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994–2000)

2001 • 126 citations

THE TRANSMISSION DYNAMICS AND CONTROL OF HEPATITIS B VIRUS IN THE GAMBIA

1996 • 119 citations

Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity.

2000 • 98 citations

Economic Evaluations of Varicella Vaccination Programmes

2003 • 93 citations

Discounting costs and effects: a reconsideration

1998 • 91 citations

Cost-benefit analysis of a nationwide infant immunization programme against hepatitis A in an area of intermediate endemicity

2001 • 54 citations

Review of European guidelines for economic evaluation of medical technologies and pharmaceuticals

2000 • 49 citations

Clinical and Economic Impact of a Combination Haemophilus influenzae and Hepatitis B Vaccine

1999 • 41 citations

Universal or selective immunisation against hepatitis B virus in the United Kingdom? A review of recent cost-effectiveness studies.

1998 • 32 citations

Economic evaluations applied to HB vaccination: general observations

1998 • 28 citations